TIM-1 Rabbit Polyclonal Antibody

TIM-1 Rabbit Polyclonal Antibody

 

Polyclonal TIM-1 Antibody

APG02985G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-1 . This antibody is tested and proven to work in the following applications:

Polyclonal TIM-1 Antibody

APG02986G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-1 . This antibody is tested and proven to work in the following applications:

TIM-1 Polyclonal Antibody

ES8662-100ul ELK Biotech 100ul 334.8 EUR
Description: A Rabbit Polyclonal antibody against TIM-1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

TIM-1 Polyclonal Antibody

ES8662-50ul ELK Biotech 50ul 248.4 EUR
Description: A Rabbit Polyclonal antibody against TIM-1 from Human. This antibody is tested and validated for WB, ELISA, WB, ELISA

Anti-TIM 3/HAVCR2 Antibody

A00657-1 BosterBio 100ug/vial 352.8 EUR

HRP-Goat Anti-Rabbit Secondary Antibody

A12004 EpiGentek
  • 232.26 EUR
  • 117.70 EUR
  • 350 µg
  • 350 ug

TIM-1 Antibody

3811-002mg ProSci 0.02 mg 206.18 EUR
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma.

TIM-1 Antibody

3811-01mg ProSci 0.1 mg 523.7 EUR
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma.

TIM-1 Antibody

3809-002mg ProSci 0.02 mg 206.18 EUR
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma.

TIM-1 Antibody

3809-01mg ProSci 0.1 mg 523.7 EUR
Description: TIM-1 Antibody: The human form of TIM-1 was initially discovered as a membrane glycoprotein through which the hepatitis A virus can gain entry into a cell. It was also identified as kidney injury molecule 1 (Kim-1), a predicted adhesion molecule that is upregulated on the surfaces of kidney epithelia. It is also expressed on T helper 2 (Th2) cells of the immune system, and following the binding of its natural ligand TIM-4, stimulates T cell expansion and cytokine production in response to viral challenge. It has been suggested that hyperactivation of TIM-1 leads to an increased level of Th2 responsiveness and asthma susceptibility, and antibodies to TIM-1 may therefore be a novel approach to treating asthma.

TIM-1 Antibody

24416-100ul SAB 100ul 468 EUR

TIM-1 Antibody

24417-100ul SAB 100ul 468 EUR

Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated

A12001 EpiGentek
  • 232.26 EUR
  • 117.70 EUR
  • 350 µg
  • 350 ug

Oncogene TIM Polyclonal Antibody

ABP56598-003ml Abbkine 0.03ml 189.6 EUR
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240

Oncogene TIM Polyclonal Antibody

ABP56598-01ml Abbkine 0.1ml 346.8 EUR
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240

Oncogene TIM Polyclonal Antibody

ABP56598-02ml Abbkine 0.2ml 496.8 EUR
Description: A polyclonal antibody for detection of Oncogene TIM from Human, Mouse, Rat. This Oncogene TIM antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human Oncogene TIM at AA range: 160-240

Polyclonal Tim-3 Antibody

APR00202G Leading Biology 0.1mg 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human Tim-3 . This antibody is tested and proven to work in the following applications:

Polyclonal TIM-4 Antibody

APR06408G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications:

Polyclonal TIM-4 Antibody

APR06409G Leading Biology 0.1 mg 790.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIM-4 . This antibody is tested and proven to work in the following applications:

Oncogene TIM Polyclonal Antibody

ES7597-100ul ELK Biotech 100ul 334.8 EUR
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

Oncogene TIM Polyclonal Antibody

ES7597-50ul ELK Biotech 50ul 248.4 EUR
Description: A Rabbit Polyclonal antibody against Oncogene TIM from Human/Mouse/Rat. This antibody is tested and validated for WB, ELISA, WB, ELISA

TIM-1

MO15036 Neuromics 100 ug 710.4 EUR

Anti-TIM-1 antibody

STJ98725 St John's Laboratory 200 µl 236.4 EUR
Description: Rabbit polyclonal to TIM-1.

Anti-TIM-1 antibody

STJ73133 St John's Laboratory 100 µg 430.8 EUR

TIM antibody

10R-10306 Fitzgerald 100 ug 522 EUR
Description: Mouse monoclonal TIM antibody

TIM antibody

10R-10307 Fitzgerald 100 ug 522 EUR
Description: Mouse monoclonal TIM antibody

TIM-1 Antibody (KIM-1)

R30715 NSJ Bioreagents 100 ug 419 EUR

TIM-1 Peptide

43-672P ProSci 0.1 mg 405.6 EUR

TIM-1 Peptide

3811P ProSci 0.05 mg 197.7 EUR
Description: (IN) TIM-1 peptide

TIM-1 Peptide

3809P ProSci 0.05 mg 197.7 EUR
Description: (NT) TIM-1 peptide

anti-TIM 1

YF-PA18329 Abfrontier 50 ug 435.6 EUR
Description: Mouse polyclonal to TIM 1

anti-TIM 1

YF-PA18330 Abfrontier 100 ug 483.6 EUR
Description: Rabbit polyclonal to TIM 1

anti-TIM 1

YF-PA26016 Abfrontier 50 ul 400.8 EUR
Description: Mouse polyclonal to TIM 1

Polyclonal Goat Anti-TIM-1 Antibody (internal region)

APR11107G Leading Biology 0.1mg 580.8 EUR
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-TIM-1 (internal region). This antibody is tested and proven to work in the following applications:

Anti-TIM 1/HAVCR1 Antibody

A01306 BosterBio 100ug/vial 352.8 EUR

Anti-TIM 1/HAVCR1 Antibody

PA1624 BosterBio 100ug/vial 400.8 EUR

Anti-TIM 1/HAVCR1 Antibody

PA1632 BosterBio 100ug/vial 400.8 EUR

Anti-TIM 1/HAVCR1 Antibody

RP1093 BosterBio 100ug/vial 352.8 EUR

Human Triosephosphate Isomerase (TIM) AssayMax ELISA Kit

ET3025-1 AssayPro 96 Well Plate 500.4 EUR

KIM-1 Antibody / TIM-1 / HAVCR1

R32305 NSJ Bioreagents 100 ug 419 EUR

KIM-1 Antibody / TIM-1 / HAVCR1

RQ4572 NSJ Bioreagents 100ug 419 EUR

TIM-4 Antibody

3813-002mg ProSci 0.02 mg 206.18 EUR
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma.

TIM-4 Antibody

3813-01mg ProSci 0.1 mg 523.7 EUR
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma.

TIM-4 Antibody

3815-002mg ProSci 0.02 mg 206.18 EUR
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma.

TIM-4 Antibody

3815-01mg ProSci 0.1 mg 523.7 EUR
Description: TIM-4 Antibody: The T cell immunoglobulin and mucin domain containing protein (TIM) family encodes cell surface receptors that are involved in the regulation of T helper (Th) -1 and -2 cell-mediated immunity. TIM-4, which is preferentially expressed on macrophages and dendritic cells, is the natural ligand of TIM-1, and this binding leads to T-cell expansion and cytokine production. Unlike other members of the TIM family, TIM-4 lacks a putative tyrosine phosphorylation signal sequence in its intracellular domain. The TIM-4 gene maps to a locus associated with predisposition to asthma in both mice and humans and with its connection to TIM-1-triggered Th2 responsiveness, may be considered as a candidate disease/predisposition gene for asthma.

Tim-3 Antibody

3808-100 Biovision 379.2 EUR

Tim-3 Antibody

3808-30T Biovision 175.2 EUR

TIM-4 Antibody

24418-100ul SAB 100ul 468 EUR

TIM-4 Antibody

24419-100ul SAB 100ul 468 EUR

TIM-3 Antibody

8659-002mg ProSci 0.02 mg 206.18 EUR
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3).

TIM-3 Antibody

8659-01mg ProSci 0.1 mg 523.7 EUR
Description: The immune checkpoint protein TIM-3 is a member of the immunoglobulin superfamily and TIM family of proteins that was initially identified as a specific marker of fully differentiated IFN-γ producing CD4 T helper 1 (Th1) and CD8 cytotoxic cells. It is a Th1-specific cell surface protein that regulates macrophage activation and negatively regulates Th1-mediated auto- and alloimmune responses, and is also highly expressed on regulatory T cells, monocytes, macrophages, and dendritic cells (1). TIM-3 and PD-1 are co-expressed on most CD4 and CD8 T cells infiltrating solid tumors or in hematologic malignancy in mice; blocking TIM-3 in conjugation with a PD-1 blockade increases the functionality of exhausted T cells and synergizes with to inhibit tumor growth (2,3).

TIM 4 Antibody

DF13636 Affbiotech 100ul 420 EUR

TIM-3 Antibody

R34699-100UG NSJ Bioreagents 100 ug 399 EUR

Tim-1 Recombinant Protein

90-546 ProSci 100 ug 752.1 EUR
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. TIM-1 (T cell-immunoglobulinmucin; also KIM-1 and HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of TIM1. One is a long (359 aa) kidney form termed TIM-1b, and one is a short (334 aa) liver form termed TIM-1a. TIM-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation.

Tim-1 Recombinant Protein

90-547 ProSci 100 ug 752.1 EUR
Description: The TIM (T cell/transmembrane, immunoglobulin and mucin) family plays a critical role in regulating immune responses, including allergy, asthma, transplant tolerance, autoimmunity and the response to viral infections. The unique structure of TIM immunoglobulin variable region domains allows highly specific recognition of phosphatidylserine (PtdSer), exposed on the surface of apoptotic cells. Tim-1 (KIM-1; HAVcr-1) is a 100 kDa, type I transmembrane glycoprotein member of the TIM family of immunoglobulin superfamily molecules. There are two cytoplasmic alternate splice forms of Tim-1. One is a long (359 aa) kidney form termed Tim-1b, and one is a short (334 aa) liver form termed Tim-1a. Tim-1, important for asthma and allergy, is preferentially expressed on T-helper 2 (Th2) cells and functions as a potent costimulatory molecule for T cell activation.

Tim-1, Human Recombinant

P1351-10 Biovision 196.8 EUR

Tim-1, Human Recombinant

P1351-50 Biovision 627.6 EUR

Tim-1, Mouse Recombinant

P1354-10 Biovision 196.8 EUR

Tim-1, Mouse Recombinant

P1354-50 Biovision 627.6 EUR

Anti-TIM 1 (2G11)

YF-MA18139 Abfrontier 100 ug 435.6 EUR
Description: Mouse monoclonal to TIM 1

Anti-TIM 1 (1E5)

YF-MA11444 Abfrontier 100 ug 435.6 EUR
Description: Mouse monoclonal to TIM 1

Anti-TIM 1 (2B9)

YF-MA11445 Abfrontier 100 ug 435.6 EUR
Description: Mouse monoclonal to TIM 1

Polyclonal TIMD4 / TIM4 / TIM-4 Antibody (Internal)

APR02384G Leading Biology 0.05mg 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human TIMD4 / TIM4 / TIM-4 (Internal). This antibody is tested and proven to work in the following applications:

Polyclonal HAVCR2 / TIM-3 Antibody (aa176-194)

APR03015G Leading Biology 0.05ml 580.8 EUR
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human HAVCR2 / TIM-3 (aa176-194). This antibody is tested and proven to work in the following applications:

Goat Anti Human Tim-3 Polyclonal Antibody

CPBT-65285GH Creative Diagnostics 0.1 mg 1008 EUR

Histone H3K4 Methylation Antibody Panel Pack

C10005 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3K9 Methylation Antibody Panel Pack

C10006 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3K27 Methylation Antibody Panel Pack

C10007 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3K36 Methylation Antibody Panel Pack

C10008 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3K79 Methylation Antibody Panel Pack

C10009 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H4K20 Methylation Antibody Panel Pack

C10012 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H4 Acetylation Antibody Panel Pack

C10013 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 4 x 25 µg
  • 4 x 25 ul

Histone H3 Phosphorylation Antibody Panel Pack

C10014 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3R2 Methylation Antibody Panel Pack

C10015 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3R8 Methylation Antibody Panel Pack

C10016 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3R17 Methylation Antibody Panel Pack

C10017 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H3R26 Methylation Antibody Panel Pack

C10018 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

Histone H4R3 Methylation Antibody Panel Pack

C10019 EpiGentek
  • 754.26 EUR
  • 470.80 EUR
  • 3 x 25 µg
  • 3 x 25 ul

DNA Methylation Antibody Panel Pack I

C20000 EpiGentek
  • 458.46 EUR
  • 270.60 EUR
  • 2 x 25 ul

HRP-Goat Anti-Mouse Secondary Antibody

A12003 EpiGentek
  • 232.26 EUR
  • 117.70 EUR
  • 350 µg
  • 350 ug

Triosephosphate Isomerase (TIM) Antibody

20-abx141692 Abbexa
  • 444.00 EUR
  • 727.20 EUR
  • 360.00 EUR
  • 100 ul
  • 200 ul
  • 50 ul

Triosephosphate Isomerase (TIM) Antibody

20-abx018098 Abbexa
  • 460.80 EUR
  • 126.00 EUR
  • 100 ug
  • 20 ug

Triosephosphate Isomerase (TIM) Antibody

abx018099-100ug Abbexa 100 ug 460.8 EUR

Anti-Oncogene TIM antibody

STJ94826 St John's Laboratory 200 µl 236.4 EUR
Description: Rabbit polyclonal to Oncogene TIM.

TIM-3 Antibody / HAVCR2

RQ4354 NSJ Bioreagents 100 ug 419 EUR

TIM-3 Antibody / HAVCR2

V8495-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8495-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8495SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8724-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8724-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8724SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8753-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8753-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8753SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8754-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8754-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8754SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8755-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8755-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8755SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cel tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8766-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8766-20UG NSJ Bioreagents 20 ug 219 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V8766SAF-100UG NSJ Bioreagents 100 ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cells (CD4+ Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

TIM-3 Antibody / HAVCR2

V9177-100UG NSJ Bioreagents 100ug 499 EUR
Description: TIMs are type I transmembrane glycoproteins with one Ig-like V-type domain and a Ser/Thr-rich mucin stalk. TIM-3 is expressed on the surface of effector T cell tonsil, lymph node or spleen. ls (CD4+Th1 and CD8+Tc1) but not on helper T cells (CD4+Th2 and CD8+Tc2). In chronic inflammation, autoimmune disorders, and some cancers, TIM-3 is upregulated on several other hematopoietic cell types. The Ig domain of TIM-3 interacts with a ligand on resting but not activated Th1 and Th2 cells. The glycosylated Ig domain of TIM-3 binds cell-associated galectin-9. This induces TIM-3 Tyr phosphorylation and pro-apoptotic signaling. TIM-3 functions as a negative regulator of Th1 cell activity. Its blockade results in increased IFN-gamma production, Th1 cell proliferation and cytotoxicity, regulatory T cell development, and increases in macrophage and neutrophil infiltration into sites of inflammation.

 

TIM-1 Rabbit Polyclonal Antibody